The Patent Finder

Sanofi Pasteur Vaxdesign Corporation

Also on record
Records under this name other than the patents Sanofi Pasteur Vaxdesign Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.

Back to Sanofi Pasteur Vaxdesign Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,962,319Methods for Testing an Immune Response Using Cultures of T Cells, B Cells, Dendritic Cells and Follicular Dendritic Cells
No holder on record
Term ended
Ended no later than Aug 10, 2026 · Low confidence
Term endedEnded no later than Aug 10, 2026Low confidence
US 7,785,883Automatable Artificial Immune System (AIS)
Term ended
Term ended Jul 27, 2026 · High confidence
Term endedTerm ended Jul 27, 2026High confidence
US 7,855,074Artificial Immune System: Methods for Making and Use
Term ended
Term ended Jul 27, 2026 · High confidence
Term endedTerm ended Jul 27, 2026High confidence
US 7,785,806Method for Determining the Immunogenicity of an Antigen
Term ended
Term ended Mar 27, 2026 · High confidence
Term endedTerm ended Mar 27, 2026High confidence
US 8,298,823Methods for Antibody Production
Term ended
Ended no later than Jan 29, 2026 · Medium confidence
Term endedEnded no later than Jan 29, 2026Medium confidence
US 9,625,444Artificial Immune System: Methods of Use
Term ended
Term ended Nov 23, 2025 · Medium confidence
Term endedTerm ended Nov 23, 2025Medium confidence
US 8,288,159Artificial Immune System: Methods for Making and Use
Term ended
Ended no later than Sep 22, 2025 · Medium confidence
Term endedEnded no later than Sep 22, 2025Medium confidence
US 7,709,256Disease Model Incorporation into an Artificial Immune System (AIS)
Term ended
Term ended Jun 6, 2025 · High confidence
Term endedTerm ended Jun 6, 2025High confidence
US 7,771,999Disease Model Incorporation into an Artificial Immune System (AIS)
Term ended
Term ended Jun 6, 2025 · High confidence
Term endedTerm ended Jun 6, 2025High confidence
US 8,071,373Co-Culture Lymphoid Tissue Equivalent (LTE) for an Artificial Immune System (AIS)
Term ended
Term ended May 6, 2025 · Medium confidence
Term endedTerm ended May 6, 2025Medium confidence
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited